September 8, 2023 Comments Off on New patent for Tarsus drug XDEMVY Posted in: Patent Added Annual Drug Patent Expirations for XDEMVY Xdemvy is a drug marketed by Tarsus and is included in one NDA. It is available from one supplier. The generic ingredient in XDEMVY…
The post New patent for Tarsus drug XDEMVY appeared first on DrugPatentWatch …
September 8, 2023 Comments Off on New patent expiration for Merck Sharp drug TEMODAR Posted in: Uncategorized
Annual Drug Patent Expirations for TEMODAR Temodar is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three…
The post New patent expiration for Merck Sharp drug TEMODAR appeared first on Dr…
